DCOY Decoy Therapeutics Inc.

Fundamentals / CIK 0001615219 / USD

Decoy Therapeutics Inc. reported $8.79M in total assets and a net loss of $16.56M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DCOY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$9.33M$4.66M$0-$37.37MFY 2016 Revenue: $1.01MFY 2016 Net Income: -$39.49M2016FY 2017 Revenue: $1.27MFY 2017 Net Income: -$34.43M2017FY 2018 Revenue: $1.95MFY 2018 Net Income: -$1.67M2018FY 2019 Revenue: $3.47MFY 2019 Net Income: -$6.94M2019FY 2020 Revenue: $5.23MFY 2020 Net Income: -$7.35M2020FY 2021 Revenue: $1.84MFY 2021 Net Income: -$12.77M2021FY 2022 Revenue: $0FY 2022 Net Income: -$31.61M2022FY 2023 Net Income: -$12.54M2023FY 2024 Net Income: -$5.58M2024FY 2025 Net Income: -$12.52M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $0 $1.84M $5.23M $3.47M $1.95M $1.27M $1.01M
Cost of Revenue -- -- -- -- -- -- -- $431K $507K $663K
Gross Profit -- -- -- -- -- -- -- $1.52M $768K $348K
Research & Development $368K $770K $7.17M $15.84M $8.55M $6.91M $4.02M $1.29M $16.99M $20.38M
Total Operating Expenses $12.61M $5.73M $12.89M $31.84M $14.65M $13.02M $11.73M $3.64M $36.00M $40.90M
Operating Income -$12.61M -$5.73M -$12.89M -$31.84M -$12.81M -$7.79M -$8.27M -$1.68M -$34.73M -$39.89M
EBITDA -$12.61M -$5.73M -$12.88M -$31.83M -$12.79M -$7.77M -$8.14M -$1.67M -$34.40M -$39.61M
Interest Income -- -- -- -- -- -- -- $152K $292K $393K
Income Tax Expense $0 -- -- -- -- -- $0 -- -- --
Net Income -$12.52M -$5.58M -$12.54M -$31.61M -$12.77M -$7.35M -$6.94M -$1.67M -$34.43M -$39.49M
Basic EPS -$5,361,295.68 -$2,887,873.75 -$229,876,003.56 -$890,189,963.03 -$461,845,867.92 -$747,807,428.62 -$3,170,703,497.35 -$1,734,913,234.40 -$2,976,273,565.90 -$3,634,344,103.09
Diluted EPS -$5,361,295.68 -$2,887,873.75 -$229,876,003.56 -$890,189,963.03 -$461,845,867.92 -$747,807,428.62 -$3,170,703,497.35 -$1,734,913,234.40 -$2,976,273,565.90 -$3,634,344,103.09
Basic Shares Outstanding 2 2 0 0 0 0 0 0 0 0
Diluted Shares Outstanding 2 2 0 0 0 0 0 0 0 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $307K $228K -- -- $0 $0 -- --
Research & Development $1.57M $1.30M $750K $114K $62K $116K $76K $175K
Total Operating Expenses $3.32M $2.63M $2.28M $9.03M $895K $966K $1.72M $1.49M
Operating Income -$3.01M -$2.63M -$2.28M -$9.03M -$895K -$966K -$1.72M -$1.49M
EBITDA -$2.99M -$2.62M -$2.28M -$9.03M -$894K -$964K -$1.72M -$1.49M
Net Income -$2.99M -$2.37M -$2.22M -$8.98M -$873K -$958K -$1.71M -$1.46M
Basic EPS -$3.53 -$4.46 -$746.43 -- -$21.76 -$81.21 -$42,869.64 --
Diluted EPS -$3.53 -$4.46 -$746.43 -- -$21.76 -$81.21 -$42,869.64 --
Basic Shares Outstanding 845.4K 532.0K 3.0K -- 40.1K 11.8K 40 --
Diluted Shares Outstanding 845.4K 532.0K 3.0K -- 40.1K 11.8K 40 --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $10.71M $2.43M $5.90M $12.11M $29.21M $11.12M $3.74M $3.23M $19.19M $22.42M
Short-Term Investments -- -- -- -- -- -- -- $0 $14.13M $38.66M
Cash & Short-Term Investments $10.71M $2.43M $5.90M $12.11M $29.21M $11.12M $3.74M $3.23M $33.32M $61.07M
Accounts Receivable, Net -- -- -- -- $1.60M $3.90M $0 $9.9K $10K $12K
Inventory -- -- -- -- -- -- -- $187K $432K $454K
Other Current Assets $275K $44K $151K $168K $173K $138K $136K $22K -- --
Total Current Assets $10.99M $2.99M $6.52M $14.52M $30.16M $15.80M $4.69M $6.38M $34.54M $62.47M
Property, Plant & Equipment, Net $41K $0 -- -- $7.9K $23K $25K $38K $331K $556K
Goodwill -- -- -- $0 $8.87M $8.87M $8.87M $0 -- --
Long-Term Investments -- -- -- -- -- -- -- -- -- $0
Other Non-Current Assets $31K $35K $67K $131K $194K $247K $309K $195K $0 $65K
Total Non-Current Assets $72K $35K $67K $131K $10.67M $9.14M $9.20M $233K $458K $748K
Total Assets $11.06M $3.02M $6.59M $14.65M $40.83M $24.93M $13.89M $6.61M $34.99M $63.21M
Accounts Payable $941K $937K $603K $2.86M $1.54M $1.85M $1.79M $380K $2.00M $1.19M
Deferred Revenue (Current) -- -- -- -- -- $0 $542K $4.01M $72K $88K
Other Current Liabilities $2.3K $0 -- -- -- -- -- -- -- --
Total Current Liabilities $5.17M $1.51M -- -- -- -- -- $1.11M $5.85M $3.89M
Other Non-Current Liabilities -- -- -- -- -- -- -- -- -- $0
Total Non-Current Liabilities $0 $0 -- -- -- -- -- $6.78M $39K $8.4K
Total Liabilities $5.17M $1.51M $1.30M $4.27M $2.11M $2.77M $3.31M $7.88M $5.89M $3.90M
Common Stock $53 $1 $49 $225 $181 $2.4K $451 $203 $1.8K $1.7K
Retained Earnings -$94.44M -$81.92M -$76.35M -$63.81M -$32.20M -$19.43M -$12.08M -$5.14M -$111.1M -$76.65M
Accumulated Other Comp. Income -- -- -- -- -- -- -- $0 -$1.2K -$1.6K
Total Stockholders' Equity $5.89M $1.51M $5.29M $10.38M $38.72M $22.16M $10.58M -$1.27M -$2.90M $59.32M
Total Equity $5.89M $1.51M $5.29M $10.38M $38.72M $22.16M $10.58M -$1.27M -$2.90M $59.32M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $8.17M $8.29M $7.82M $10.71M $4.81M $795K $1.80M $2.43M
Cash & Short-Term Investments $8.17M $8.29M $7.82M $10.71M $4.81M $795K $1.80M $2.43M
Other Current Assets $209K $146K $306K $275K $81K $26K $62K $44K
Total Current Assets $8.38M $8.57M $8.36M $10.99M $6.06M $1.36M $2.31M $2.99M
Property, Plant & Equipment, Net $385K $399K $36K $41K -- -- -- $0
Other Non-Current Assets $28K $29K $30K $31K $32K $33K $34K $35K
Total Non-Current Assets $413K $428K $66K $72K $32K $33K $34K $35K
Total Assets $8.79M $9.00M $8.42M $11.06M $6.10M $1.39M $2.34M $3.02M
Accounts Payable $779K $1.33M $936K $941K $1.10M $1.48M $1.47M $937K
Other Current Liabilities -- -- -- $2.3K -- -- -- $0
Total Current Liabilities $4.25M $4.68M $4.55M $5.17M -- -- -- $1.51M
Total Non-Current Liabilities $0 $0 $0 $0 -- -- -- $0
Total Liabilities $4.25M $4.68M $4.55M $5.17M $1.85M $2.22M $2.28M $1.51M
Common Stock $238 $53 $53 $53 $94 $213 $208 $1
Retained Earnings -$102.0M -$99.04M -$96.67M -$94.44M -$85.46M -$84.59M -$83.63M -$81.92M
Total Stockholders' Equity $4.55M $4.32M $3.88M $5.89M -$4.25M -$830K $62K $1.51M
Total Equity $4.55M $4.32M $3.88M $5.89M -$4.25M -$830K $62K $1.51M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$12.52M -$5.58M -$12.54M -$31.61M -$12.77M -$7.35M -$6.94M -$1.67M -$34.43M -$39.49M
Depreciation & Amortization $7.2K $4.4K $10K $6.7K $19K $18K $127K $17K $325K $277K
Stock-Based Compensation $219K $274K $525K $797K $559K $319K $752K $31K $4.22M $6.57M
Change in Receivables -- -- -- -- -- $0 $690 $0 $1.8K -$12K
Change in Inventory -- -- -- -- -- $0 $1.2K $0 $22K -$454K
Change in Payables -$1.17M $334K -$2.26M $1.31M -$311K -$2.8K -$519K -$285K $819K $309K
Operating Cash Flow -$4.83M -$4.53M -$12.85M -$17.60M -$10.20M -$10.31M -$11.58M $4.18M -$27.72M -$32.05M
Capital Expenditure -$577K $0 -- -- $0 -$2.6K $0 $0 -$113K -$559K
Free Cash Flow -$5.40M -$4.53M -- -- -$10.20M -$10.31M -$11.58M $4.18M -$27.84M -$32.61M
Purchases of Investments -- -- -- -- -- -- -- -$2.00M -$32.99M -$38.68M
Investing Cash Flow $765K $0 $0 -$1.50M $0 -$2.6K $5.61M $0 $24.49M -$12.24M
Common Stock Issued -- -- -- -- -- -- $4.13M $2.87M -- --
Share Repurchases -- -- -- -- -- -- $0 -$615K -- --
Dividends Paid -- -- -- -- -- $0 -$134K $0 -- --
Financing Cash Flow $12.34M $1.06M $6.64M $1.99M $28.30M $17.69M $3.58M $1.44M $2.6K $22K
Net Change in Cash $8.28M -$3.47M -$6.21M -$17.11M $18.10M $7.38M -$2.39M $5.61M -$3.23M -$44.27M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.99M -$2.37M -$2.22M -$8.98M -$873K -$958K -$1.71M -$1.46M
Depreciation & Amortization $25K $14K $5.9K $3.8K $1.1K $1.1K $1.1K $1.1K
Stock-Based Compensation $253K $206K $213K $140K $23K $23K $34K $51K
Change in Payables $35K -$231K -$4.6K -$1.19M -$311K $83K $255K $771K
Operating Cash Flow -$2.59M -$2.65M -$2.89M -$1.14M -$1.65M -$862K -$1.18M -$743K
Financing Cash Flow $2.55M $3.16M $0 $6.07M $5.86M -$141K $546K -$107K
Net Change in Cash -$121K $468K -$2.89M $5.90M $4.01M -$1.00M -$636K -$850K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -- -- -- 77.9% 60.3% 34.4%
Operating Margin -- -- -- -- -696.3% -148.8% -238.5% -86.3% -2724.6% -3946.5%
Net Profit Margin -- -- -- -- -693.8% -140.5% -200.2% -85.6% -2701.7% -3907.6%
Return on Equity (ROE) -212.6% -368.8% -237.2% -304.4% -33.0% -33.2% -65.6% -- -- -66.6%
Return on Assets (ROA) -113.2% -184.4% -190.4% -215.7% -31.3% -29.5% -49.9% -25.2% -98.4% -62.5%
Current Ratio 2.13x 1.98x -- -- -- -- -- 5.76x 5.91x 16.06x
Quick Ratio 2.07x 1.61x -- -- -- -- -- 5.60x 5.83x 15.94x
Revenue Growth (YoY) -- -- -- -100.0% -64.8% +51.0% +77.6% +53.1% +26.1% --
Gross Profit Growth (YoY) -- -- -- -- -- -- -- +98.0% +120.7% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -377.2% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -377.2% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -364.3% -334.4% -336.1% -212.6% -- -- -9003.4% -368.8%
Return on Assets (ROA) -188.4% -160.5% -154.7% -113.2% -82.1% -366.4% -238.1% -184.4%
Current Ratio 1.97x 1.83x 1.84x 2.13x -- -- -- 1.98x
Quick Ratio 1.92x 1.77x 1.72x 2.07x -- -- -- 1.61x
Source: SEC EDGAR CompanyFacts (CIK 0001615219) · from June 30, 2014 Data through September 30, 2026 · synced Nov 21, 2026, 05:14 UTC · Open in terminal